Shanghai Rightongene (China) Performance
| 688217 Stock | 22.43 0.20 0.90% |
Shanghai Rightongene has a performance score of 4 on a scale of 0 to 100. The entity has a beta of 0.68, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Shanghai Rightongene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Shanghai Rightongene is expected to be smaller as well. Shanghai Rightongene right now has a risk of 3.22%. Please validate Shanghai Rightongene mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to decide if Shanghai Rightongene will be following its existing price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rightongene Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rightongene may actually be approaching a critical reversion point that can send shares even higher in March 2025. ...more
Payout Ratio 9 | Ex Dividend Date 2023-11-30 |
1 | Tranche Update on Shanghai Rightongene Biotechnology Co., Ltd.s Equity Buyback Plan announced on February 29, 2024. - Marketscreener.com | 01/03/2025 |
| Begin Period Cash Flow | 203.2 M |
Shanghai |
Shanghai Rightongene Relative Risk vs. Return Landscape
If you would invest 2,089 in Shanghai Rightongene Biotechnology on November 29, 2024 and sell it today you would earn a total of 154.00 from holding Shanghai Rightongene Biotechnology or generate 7.37% return on investment over 90 days. Shanghai Rightongene Biotechnology is generating 0.1754% of daily returns and assumes 3.2151% volatility on return distribution over the 90 days horizon. Simply put, 28% of stocks are less volatile than Shanghai, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Shanghai Rightongene Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shanghai Rightongene's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shanghai Rightongene Biotechnology, and traders can use it to determine the average amount a Shanghai Rightongene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0546
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688217 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.22 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Shanghai Rightongene is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shanghai Rightongene by adding it to a well-diversified portfolio.
Shanghai Rightongene Fundamentals Growth
Shanghai Stock prices reflect investors' perceptions of the future prospects and financial health of Shanghai Rightongene, and Shanghai Rightongene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shanghai Stock performance.
| Return On Equity | -0.0148 | ||||
| Return On Asset | -0.0097 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.05 B | ||||
| Shares Outstanding | 55.86 M | ||||
| Price To Book | 1.35 X | ||||
| Price To Sales | 5.01 X | ||||
| Revenue | 258.21 M | ||||
| Gross Profit | 182.74 M | ||||
| EBITDA | 25.94 M | ||||
| Net Income | 7.93 M | ||||
| Total Debt | 5.82 M | ||||
| Book Value Per Share | 14.70 X | ||||
| Cash Flow From Operations | 45.1 M | ||||
| Earnings Per Share | (0.10) X | ||||
| Total Asset | 1.04 B | ||||
| Retained Earnings | 154.03 M | ||||
About Shanghai Rightongene Performance
By analyzing Shanghai Rightongene's fundamental ratios, stakeholders can gain valuable insights into Shanghai Rightongene's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shanghai Rightongene has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shanghai Rightongene has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Shanghai Rightongene is entity of China. It is traded as Stock on SHG exchange.Things to note about Shanghai Rightongene performance evaluation
Checking the ongoing alerts about Shanghai Rightongene for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shanghai Rightongene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Shanghai Rightongene had very high historical volatility over the last 90 days | |
| Shanghai Rightongene has high likelihood to experience some financial distress in the next 2 years | |
| About 40.0% of the company shares are owned by insiders or employees |
- Analyzing Shanghai Rightongene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shanghai Rightongene's stock is overvalued or undervalued compared to its peers.
- Examining Shanghai Rightongene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shanghai Rightongene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shanghai Rightongene's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shanghai Rightongene's stock. These opinions can provide insight into Shanghai Rightongene's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shanghai Stock analysis
When running Shanghai Rightongene's price analysis, check to measure Shanghai Rightongene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Rightongene is operating at the current time. Most of Shanghai Rightongene's value examination focuses on studying past and present price action to predict the probability of Shanghai Rightongene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Rightongene's price. Additionally, you may evaluate how the addition of Shanghai Rightongene to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |